Obinutuzumab Plus Chemotherapy Compared with Rituximab Plus Chemotherapy in Previously Untreated Italian Patients with Advanced Follicular Lymphoma at Intermediate–High Risk: A Cost-Effectiveness Analysis

Marco Bellone,1 Lorenzo Pradelli,1 Stefano Molica,2 Adele Emanuela De Francesco,3 Daniela Ghislieri,4 Emanuele Guardalben,5 Antonietta Caputo4 1Department of Health Economics and Outcome Research, AdRes Health Economics and Outcomes Research, Turin, Italy; 2Dipartimento Onco-ematologico, Azienda Osp...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Bellone M (Author), Pradelli L (Author), Molica S (Author), De Francesco AE (Author), Ghislieri D (Author), Guardalben E (Author), Caputo A (Author)
Hōputu: Pukapuka
I whakaputaina: Dove Medical Press, 2021-07-01T00:00:00Z.
Ngā marau:
Urunga tuihono:Connect to this object online.
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ipurangi

Connect to this object online.

3rd Floor Main Library

Ngā taipitopito puringa mai i 3rd Floor Main Library
Tau karanga: A1234.567
Tārua 1 Wātea